The H. Pylori Infection, Erosive Esophagitis & Non-Erosive Reflux Disease in GERD
Abstract
To determine the prevalence of infection with Helicobacter pylori in GERD patients and compare the incidence of
erosive esophagitis and non-erosive reflux illness in those patients.
This descriptive cross sectional was done at Medical division of Mayo Hospital Lahore from 6th Dec 2021 to
6th June 2022.Total of 150 patients fulfilling the inclusion criteria were enrolled after taking informed consent. Endoscopy
was performed in all patients. Both non-erosive reflux disease and erosive esophagitis were found endoscopically. All
patients had tissue biopsies obtained for histopathology, which were then forwarded to the pathology lab for H. pylori
detection.
Out of 150 patients, 58.7% (88) were female and 41.3% (62) were male. These patients were between the ages of
15 and 65. They were split into two groups: younger people, whose ages ranged from 15 to 40 (mean: 26.84 ± 7.478), and
middle-aged people, whose ages ranged from 41 to 65 (mean: 51.31 ± 7.378). 32% (48) of the population was in the
middle age bracket, while 68% (102) were among the young. 13.3% (20) of the patients had erosive esophagitis, while
86.7% (130) had non-erosive reflux illness. 20% (4) of patients with erosive esophagitis and 29.23% (38) of individuals
with non-erosive reflux disease had H pylori infection. (P < 0.3).
Patients with GERD are more likely to have non-erosive reflux disease than erosive esophagitis on endoscopy,
and non-erosive reflux disease is linked to a higher incidence of helicobacter infection.
How to Cite This Article
Habib M, Younus I, Waseem MM, Qadir A, Iqbal S, Rasheed F. The H. Pylori Infection, Erosive Esophagitis & Non-Erosive Reflux Disease in GERD. J Pak Soc Intern Med. 2024;5(4):716–719. doi:10.70302/jpsim.v5i4.2471
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun 1;63(6):871-80.
- Nirwan JS, Hasan SS, Babar ZU, et al Conway BR, Ghori MU. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis. Scientific reports. 2020 Apr 2;10(1):5814.
- Tan VP, Wong BC, Wong WM, et al. Gastroesophageal Reflux Disease. Journal of clinical gastroenterology. 2016 Jan 1;50(1):e1-7.
- Valezi AC, Herbella FA, Schlottmann F, et al. Gastroesophageal reflux disease in obese patients. Journal of laparoendoscopic& advanced surgical techniques. 2018 Aug 1;28(8):949-52.
- Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. 2016 Sep 1;65(9):1402-15.
- Pandolfino JE, Kahrilas PJ. Helicobacter pylori and gastroesophageal reflux disease. URL http://www. uptodate. com/contents/helicobacter-pylori-and-gastroesophageal-reflux-disease. 2016.
- Bor S, Kitapcioglu G, Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World journal of gastroenterology. 2017 Jan 1;23(3):525.
- Zhao Y, Li Y, Hu J, et al. The effect of Helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies. Digestive Diseases. 2020;38(4):261-8.
- Fock KM, Talley N, Goh KL,et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. 2016 Sep 1;65(9):1402-15.
- Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clinical gastroenterology and hepatology. 2016 Feb 1;14(2):175-82.
- Serena S, Michele R, Chiara M, et al. Relationship between Helicobacter pylori infection and GERD. Acta Bio Medica: AteneiParmensis. 2018;89(Suppl 8):40.
- .
- Tan J, Wang Y, Sun X,et al. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease. The American Journal of the Medical Sciences. 2015 Apr 1;349(4):364-71.
- Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Official journal of the American College of Gastroenterology| ACG. 2007 Aug 1;102(8):1808-25.
- Jonaitis LV, Kiudelis G, Kupcinskas L. Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pylori prevalence region. Dis Esophagus. 2004;17(3):223-7.
- Rasmi Y, Sadreddin M, Shahsavari Z et al. Prevalence of helicobacter pylori and cytotoxin associated gene in Iranian patients with non-erosive reflux.Indian J Med Sci 2009; 63: 9.
- Du J, Liu J, Zhang H, et al. Risk factors for gastroesophagealreflux disease, reflux esophagitis and nonerosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol 2007; 13(45): 6009-6015.
- Gatopoulou A, Mimidis K, Giatromanolaki A et al. Impact of Helicobacter pylori infection on histological changes in non-erosive reflux disease.World J Gastroenterol 2004 ;10(8):1180-1182.
- Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best practice & research Clinical gastroenterology. 2013 Jun 1;27(3):325-37.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.